-
Pharma and Health from Ingredients to Pills: Cancer Therapeutics Today(2)
Lin Zhang
July 28, 2020
In 2015, the advantages of the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas)9-mediated genome modification......
-
Pharma and Health from Ingredients to Pills: Cancer Therapeutics Today(1)
Lin Zhang
July 28, 2020
Treatment of oncologic patients has progressed greatly in the last few years with the development of novel technologies and drugs.
-
New data shows steep rise in people waiting for cancer tests
pharmatimes
July 24, 2020
Alarm bells are ringing again over the impact of the COVID-19 pandemic on cancer care in the UK, after Cancer Research UK unveiled new data showing a steep rise in the number of people waiting for diagnostic tests, and a study published in ...
-
Cadila Pharma expands oncology portfolio with biosimilar cancer drug Bevaro
expresspharma
July 23, 2020
Cadila plans to launch multiple biosimilar products this year for the Indian market.
-
GEMoaB, Intellia Enter Cellular Immunotherapy Research Pact
contractpharma
July 21, 2020
Will combine GEMoaB's RevCAR technology platform with Intellia's genome editing technologies to discover and develop allogeneic cellular immunotherapies.
-
UK report finds low awareness of non-melanoma skin cancer
pharmatimes
July 14, 2020
Public awareness in the UK about non-melanoma skin cancer (NMSC) is 'worryingly low' and 'urgent action' is needed to improve sun protection for outdoor workers, concludes a new report by Sanofi.
-
Translated Tool from NCCN Measures Mental Health "Temperature" of People with Cancer
prnasia
July 13, 2020
The National Comprehensive Cancer Network® (NCCN®)--an alliance of leading cancer centers in the United States--today announced the NCCN Distress Thermometer has been translated into 46 languages.
-
CR UK pairs with Abcam
pharmatimes
July 09, 2020
Cancer Research UK (CR UK) has paired with Abcam to develop and commercialise novel custom antibodies to support the acceleration of cancer research.
-
Avesthagen study may help determine genetic predictors for tobacco-related cancers
expresspharma
July 09, 2020
Researchers are studying about how Zoroastrian-Parsi genes may help scientists characterize biomarkers predictive of diseases caused by tobacco use, such as lung, head and neck, and esophagus cancers.
-
Partnership gets £4.4m gov grant for better liver diagnostics
pharmatimes
July 03, 2020
Perspectum has been awarded a multimillion pound UK government research grant (UKRI) with partners for the development of new technology to help save patients’ lives by diagnosing liver disease earlier.